UK Judge Rules J&J Alzheimer Patent Invalid
A U.K. judge has ruled that a patent held by a Johnson & Johnson unit that is related to a potential treatment for Alzheimer's disease is invalid, siding with pharmaceutical maker...To view the full article, register now.
Already a subscriber? Click here to view full article